MedTrace Logo

Hyaluronic Acid Injection in the Glans Penis Versus Selective Serotonin Reuptake Inhibitors for Lifelong Premature

NCT06451406 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-06-13

No results posted yet for this study

Summary

The aim of this study was to compare the effectiveness and safety of selective serotonin reuptake inhibitors (dapoxetine) and hyaluronic acid gel injection in the glans penis for lifelong premature.

Conditions

  • Selective Serotonin Reuptake Inhibitor
  • Hyaluronic Acid
  • Glans Penis
  • Lifelong Premature

Interventions

DRUG

Selective serotonin re-uptake inhibitor

Patients received selective serotonin re-uptake inhibitor as medical treatment for treatment of premature ejaculate.

DRUG

Hyaluronic acid

Patients received injection of glans penis with hyaluronic acid

Sponsors & Collaborators

  • New Valley University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2023-06-01
Completion
2023-06-01

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06451406 on ClinicalTrials.gov